CRISPR

CRISPR2-sdc4

ID
ZDB-CRISPR-260604-1
Name
CRISPR2-sdc4
Previous Names
None
Target
Sequence
5' - GTGAGTTGCCGGAGGACTCC - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
zf4407 sdc4
Expression
Gene expression in Wild Types + CRISPR2-sdc4
No data available
Phenotype
Phenotype resulting from CRISPR2-sdc4
No data available
Phenotype of all Fish created by or utilizing CRISPR2-sdc4
Phenotype Fish Conditions Figures
muscle ATP decreased amount, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 7 from Wang et al., 2026
muscle ctnnb2 expression decreased amount, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 3 from Wang et al., 2026
whole organism decreased weight, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 2 from Wang et al., 2026
muscle axin2 expression decreased amount, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 3 from Wang et al., 2026
muscle cyc1 expression decreased amount, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 7 from Wang et al., 2026
muscle mt-atp6 expression decreased amount, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 7 from Wang et al., 2026
muscle myog expression decreased amount, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 3 from Wang et al., 2026
muscle sdc4 expression decreased amount, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 1 from Wang et al., 2026
muscle cell transverse plane decreased area, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 2 from Wang et al., 2026
muscle mt-cyb expression decreased amount, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 7 from Wang et al., 2026
muscle lef1 expression decreased amount, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 3 from Wang et al., 2026
muscle trim63a expression increased amount, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 3 from Wang et al., 2026
muscle ctnnb2 expression increased amount, abnormal sdc4zf4407/zf4407 (AB) chemical treatment by environment: lithium chloride Fig. 3 from Wang et al., 2026
muscle myod1 expression decreased amount, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 3 from Wang et al., 2026
whole organism decreased length, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 2 from Wang et al., 2026
muscle ndufb8 expression decreased amount, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 7 from Wang et al., 2026
muscle wnt3a expression increased amount, abnormal sdc4zf4407/zf4407 (AB) chemical treatment by environment: lithium chloride Fig. 3 from Wang et al., 2026
muscle apc2 expression decreased amount, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 3 from Wang et al., 2026
muscle skp1 expression decreased amount, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 3 from Wang et al., 2026
muscle wnt3a expression decreased amount, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 3 from Wang et al., 2026
muscle mt-nd5 expression decreased amount, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 7 from Wang et al., 2026
muscle pax7a expression increased amount, abnormal sdc4zf4407/zf4407 (AB) chemical treatment by injection: cardiotoxic agent Fig. 5 from Wang et al., 2026
muscle cell increased amount, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 2 from Wang et al., 2026
muscle gsk3ba expression decreased amount, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 3 from Wang et al., 2026
muscle myog expression decreased amount, abnormal sdc4zf4407/zf4407 (AB) chemical treatment by environment: lithium chloride Fig. 3 from Wang et al., 2026
muscle atp5mf expression decreased amount, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 7 from Wang et al., 2026
muscle mt-co1 expression decreased amount, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 7 from Wang et al., 2026
muscle mt-nd4 expression decreased amount, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 7 from Wang et al., 2026
swimming behavior decreased process quality, abnormal sdc4zf4407/zf4407 (AB) control Fig. 6 from Wang et al., 2026
muscle axin1 expression decreased amount, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 3 from Wang et al., 2026
muscle mt-co2 expression decreased amount, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 7 from Wang et al., 2026
muscle mymk expression decreased amount, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 3 from Wang et al., 2026
muscle mef2aa expression decreased amount, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 4 from Wang et al., 2026
muscle myf5 expression decreased amount, abnormal sdc4zf4407/zf4407 (AB) standard conditions Fig. 3 from Wang et al., 2026
Citations